Heron Therapeutics (HRTX) Reports FDA Approval of SUSTOL - StreetInsider.com

Channel NewsAsia

Heron Therapeutics (HRTX) Reports FDA Approval of SUSTOL StreetInsider.com Heron Therapeutics, Inc. (NASDAQ: HRTX), today announced that the U.S. Food and Drug Administration (FDA) has approved SUSTOL® (granisetron) extended-release injection. SUSTOL is a serotonin-3 (5-HT3) receptor antagonist indicated in combination ... UPDATE 1-FDA approves Heron's therapy for chemotherapy-induced nauseaReuters Heron Therapeutics shares rise 18% in pre-market trade after company said treatment was approved by FDAForexTV.com all 5 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHCS-1KZIg58uHP5Gcc_liF7zojcg&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779177912091&ei=5zSrV5C-L4qV3AGJ_p3YBA&url=http://www.streetinsider.com/Corporate%2BNews/Heron%2BTherapeutics%2B(HRTX)%2BReports%2BFDA%2BApproval%2Bof%2BSUSTOL/11923459.html
via IFTTT